Baroreflex activation therapy through electrical carotid sinus stimulation

• Published in: Autonomic neuroscience 2024-12, Vol.256, p.103219, Article 103219
• Main Authors: Jordan, Jens, Tank, Jens, Heusser, Karsten, Reuter, Hannes
• Format: Article
• Language: English
• Subjects: Animals; Autonomic nervous system; Baroreflex; Baroreflex - physiology; Baroreflex activation therapy; Blood Pressure - physiology; Carotid Sinus - physiology; Carotid Sinus - physiopathology; Electric Stimulation Therapy - methods; Heart failure; Heart Failure - physiopathology; Heart Failure - therapy; Humans; Hypertension; Hypertension - physiopathology; Hypertension - therapy; Parasympathetic nervous system; Sympathetic nervous system
• ISSN: 1566-0702; 1872-7484; 1872-7484
• DOI: 10.1016/j.autneu.2024.103219

An imbalance between cardiovascular parasympathetic and sympathetic activity towards sympathetic predominance has been implicated in the pathogenesis of treatment-resistant arterial hypertension and heart failure. Arterial baroreceptors control efferent cardiovascular autonomic activity and have, therefore, been recognized as potential treatment targets. Baroreflex activation therapy through electrical carotid sinus stimulation is a device-based approach to modulate cardiovascular autonomic activity. Electrical carotid sinus stimulation lowered blood pressure in various hypertensive animal models and improved cardiac remodeling and survival in preclinical models of heart failure. In human mechanistic profiling studies, electrical carotid sinus stimulation lowered blood pressure through sympathetic inhibition with substantial inter-individual variability. The first-generation device reduced blood pressure in controlled and uncontrolled clinical trials. Controlled clinical trials proving efficacy in blood pressure reduction in patients with hypertension do not exist for the currently available second-generation carotid sinus stimulator. Investigations in heart failure patients showed improved symptoms, quality of life, and natriuretic peptide biomarkers. Electrical carotid sinus stimulation is an interesting technology to modulate cardiovascular autonomic control. However, controlled trials with hard clinical endpoints are required.